BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:1st R&D Training Day in Biopharmaceuticals and Medical Devices
DTSTART:20170322T083000
DTEND:20170322T173000
DTSTAMP:20260503T174104Z
UID:c5b8d3b32dbb578c47eb114b358da5a2a6e218bb28c0c0ca48e6e538
CATEGORIES:Internal trainings
DESCRIPTION:Brigitte Happ\, PhD    Regulatory Affairs\, Happ-Consultin
 g\, Merck\, Serono\, Giba-Geigy\nKostas Kaloulis\, PhD    Business Dev
 elopment & Entrepreneurship\, EPFL\, LifeCare Partners\, ReMedys\, NsGene\
 , Merck\, Apoxis\nMariagrazia di Marco\, PhD    Medical Devices and Cl
 inical Research\, HUG\, Nanobiotix\, Guerbet\nTiziana Mattioni\, PhD   
  Precinical & Clinical Development\, Consulting\, Genenta\, Merck\, Seron
 o\nSonia Poli\, PhD    Biopharma R&D\, Poli Consulting\, Dimerix\, Add
 ex\, Roche\nElisabeth Svanberg\, PhD-MD    Clinical and Product Develo
 pment\, Ixaltis\, Janssen\, J&J\, BMS  \nAre you interested on how to tra
 nslate research into society useful applications? \nThen you are invited 
 by the School of Life Sciences and the Applied Innovation Mechanism (AIM) 
 at the VP Innovation to this 1-day course.\n6 Industry Experts will discus
 s\, and give you an overview\, on how to Pave the Path from Researchto Pro
 duct Development.\nLimited Places! \nTO REGISTER PLEASE FILL IN THIS DOOD
 LE: http://doodle.com/poll/2y5sbewhz8nzm7p7\nGoal: This course aims to int
 roduce key topics of drug and medical devices development  and medical de
 vices\nLearning objectives: At the end of the course\, the participant wil
 l be able to understand:\n·         the main principles of clinic
 al development for Drugs and Devices\n·         the border betwee
 n a drug and a medical device\n·         how to translate a proje
 ct from bench to bed\n·         the importance of Good Clinical P
 ractice\n·         the importance of project oversight\n·   
       the role of regulatory affairs in drug development\n·    
      the importance health authority engagement\n·         ke
 y elements required for partnering and licensing\nLearning methods: Lectur
 es\, case studies\n\nAbout AIM: AIM’s ambition is to Provide\; funding\,
  R&D Industry expertise and network\, business development/Planning suppor
 t and industrial network\, entrepreneurship in residence\, to help validat
 ing technologies and identifying potential industry partners\, or other 
 “exits”\, to advance these technologies to the marketplace.\nAIM’s p
 rimary goal is to advance technologies to the inflection point where addit
 ional funding from industry and/or technology transfer is feasible or achi
 eved.\nAIM’s vision is to evolve\, in alignment with all relevant stake 
 holders\, into the 1st Innovation Incubator supporting all schools at EPFL
 .\nAIM is an initiative designed to accommodate all tools and expertise in
 to supporting projects of varying magnitude\, and area.\nAIM pilot is curr
 ently supporting several projects at the School of Life Sciences.
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR